An official website of the United States government
September 29, 2026 Edition
News
Antiviral drug did not improve Long COVID symptoms
A clinical trial for Long COVID found that treating patients with a common antiviral drug for up to 25 days did not improve symptoms.
News
tRNA treatment may help restore cystic fibrosis proteins
Lipid nanoparticles delivering engineered transfer RNA restored functional proteins in cell and animal models of cystic fibrosis.
News
Bacterial infection may alter developing gut
C. difficile bacteria caused lasting changes to cells in the intestines of newborn mice.
Displaying 344 - 350 of 912
Changing long-term opioid prescribing behavior
Notifying clinicians that one of their patients died of an overdose reduced the amount of opioids they prescribed for up to a year afterwards.
Lab-grown eye cells form new neural connections
Eye cells that were grown from skin-derived stem cells could be collected from 3D cultures and coaxed to form new neural connections.
Link between hydration and aging
Higher blood sodium in middle age was associated with increased mortality, chronic disease risk, and biological aging.
Gut microbes may affect motivation to exercise
Researchers found a pathway by which gut microbes affect levels of exercise in mice. The findings, if confirmed in humans, suggest strategies to help encourage people to exercise.
Paxlovid reduces serious risks from Omicron variants
The antiviral treatment Paxlovid reduced the risk of hospitalization or death from SARS-CoV-2 Omicron variants in older adults by 44%.
Blood test for early Alzheimer's detection
Researchers developed a blood test that could detect Alzheimer's disease-promoting compounds in the blood long before symptoms emerged.
2022 Research Highlights - Human Health Advances
NIH accomplishments in disease prevention, diagnosis, and treatment include insights into Covid-19 vaccines, advances for type 1 diabetes, and a robotic exoskeleton that helps people walk.